Form 4: Intellinetics Director Acquires 6,000 Shares Through Stock Option Grant
SEC Form 4 Filing
John C. Guttilla, a director of Intellinetics, Inc., acquired 6,000 shares of common stock through a non-qualified stock option grant on August 16, 2024.
Summary
- On August 16, 2024, John C. Guttilla, a director of Intellinetics, Inc. (INLX), acquired 6,000 shares of common stock.
- The acquisition was made through a non-qualified stock option grant with an exercise price of $8.78.
- The options were granted in exchange for director services, as part of the company's 2023 Non-Employee Director Compensation Plan.
- The options are exercisable immediately and expire on August 15, 2034.
- Following the transaction, Guttilla directly owns 6,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock option grant, which is a standard compensation practice.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
- The director compensation plan incentivizes the director to contribute to the company's success over the long term.
Industry Context
This type of stock option grant is a common practice for compensating directors of publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Stock option grants for directors are a standard component of compensation packages in publicly traded companies.
- The size of the grant (6,000 shares) and the exercise price ($8.78) would need to be compared to similar companies in the same industry and of similar market capitalization to determine if it is within industry norms.
- Companies like Xerox, HP, and Canon also use stock options as part of their director compensation packages.
Stakeholder Impact
- The stock option grant could potentially increase shareholder value if the director's performance leads to an increase in the company's stock price.
- The grant provides an incentive for the director to act in the best interests of the company and its shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date of the stock option grant and transaction. |
| 08/16/2024 | Date the options become exercisable. |
| 08/15/2034 | Expiration date of the stock options. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.